The FDA announced on July 23, 2026, that Glenmark Pharmaceuticals Inc., USA is recalling Azelaic Acid Gel, 15% due to CGMP deviations resulting in abnormal texture. The agency classified the recall as Class II.
How to tell if you have it
- Brand: Glenmark
- Product: Azelaic Acid Gel, 15%, 50 gram tubes
- NDC: 68462-626-52
- Lot codes: 19260937A (Exp. Feb 2028); 19261225A, 19261185A (Exp. Mar 2028); 19261664A, 19261682A (Exp. Apr 2028)
- Distribution: Nationwide within the United States
The hazard
The FDA stated that product quality complaints concerning abnormal texture or consistency, described as grainy, gritty, or sandy, were received regarding this recall.
Context
GovInfoNow's records show Glenmark Pharmaceuticals Inc., USA has 54 other recalls on record since November 20, 2017. Other recent recalls of similar products include Sun Pharmaceutical Diclofenac Gel Recall (January 27, 2026), Keystone Pearson Topical Anesthetic Gel Recall (May 21, 2026) and Keystone DHP Topical Anesthetic Gel Recall (May 21, 2026).